Home Journals Subjects About My LA Reviewers Authors News Submit
Username: Password:
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement
 
 
 

Clinical Medicine: Arthritis and Musculoskeletal Disorders

Synopsis: An open access, peer reviewed electronic journal that covers the treatment of arthritis, autoimmune disease and bone and cartilage conditions.


Indexing: 5 major databases. Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.

Visibility: Most popular article read 1000+ times.


Latest news:

4,996 article downloads per month. 

Click to see more open access visibility statistics.

RSS

NEWS

TWITTER
View factor:
Journal: 34077
Most read article: 2425
Editor in chief:
Tariq M. Haqqi
ISSN: 1178-1149


 
 
 

Clinical Medicine: Arthritis and Musculoskeletal Disorders call for papers from Dr Tariq Haqqi


It is my pleasure to invite you to submit your recent work for publication in Clinical Medicine: Arthritis and Musculoskeletal Disorders—a new peer reviewed open access journal published by Libertas Academica.

The global aging of the population and the increasing prevalence of arthritis and other age related disorders has raised the need to develop a better understanding of the underlying mechanisms as well as a better diffusion of the scientific information not only to health professionals but also to the general population.

As an open access journal, Clinical Medicine: Arthritis and Musculoskeletal Disorders provide you the unique opportunity to share your results with all internet users without any restriction. This will provide your peers as well as the general community a direct access to your work. This will ensure a fast and efficient dissemination of your important scientific contributions to a large number of readers, from scientists to patients.

The focus of the journal not only covers fundamental and clinical aspects of arthritis in all populations, but also strategies to improve the care of patients. This offers a unique opportunity to report on translational approaches investigating from the molecular to the whole body level, mechanisms in the aging process or in the prevention of disorders associated with it.

Manuscripts submitted to the journal are reviewed through a fair and constructive process by leading experts in the field of arthritis and musculoskeletal disorders including autoimmune diseases (from molecular to whole body level). This guarantees high quality publications in a timely manner, more than 90% of the submitted manuscripts being reviewed within 2 weeks.

I invite you to take full advantage of this opportunity and to submit your work for publication in Clinical Medicine: Arthritis and Musculoskeletal Disorders.

What is the advantage to you of publishing in Clinical Medicine: Arthritis and Musculoskeletal Disorders?
  • Full open access: everyone can read your article and you retain copyright in it
  • Publishing decision within 2 weeks of submission
  • Your paper will not be rejected due to lack of space and will be published immediately on acceptance
  • Prompt and fair peer review from two expert peer reviewers
  • Frequent updates on your paper’s status
  • Friendly responsive staff
What a previous author said:
"I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."
In summary:

The advantages of a younger journal such as Clinical Medicine: Arthritis and Musculoskeletal Disorders are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.

Next steps:

Yours sincerely,
Dr Tariq Haqqi

Editor-in-Chief
Clinical Medicine: Arthritis and Musculoskeletal Disorders